SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday

SOPHiA GENETICS (NASDAQ:SOPH) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 7th. Analysts expect SOPHiA GENETICS to post earnings of ($0.28) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

SOPHiA GENETICS (NASDAQ:SOPH) last announced its quarterly earnings data on Tuesday, March 5th. The company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.12). SOPHiA GENETICS had a negative net margin of 126.63% and a negative return on equity of 47.40%. The business had revenue of $17.05 million for the quarter, compared to analyst estimates of $16.78 million. During the same quarter in the previous year, the firm posted ($0.22) earnings per share. On average, analysts expect SOPHiA GENETICS to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

SOPHiA GENETICS Price Performance

Shares of SOPHiA GENETICS stock opened at $5.00 on Monday. The firm has a fifty day moving average price of $4.93 and a 200 day moving average price of $4.55. SOPHiA GENETICS has a 1 year low of $2.13 and a 1 year high of $7.37.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price objective on shares of SOPHiA GENETICS in a research report on Wednesday, March 6th. BTIG Research increased their price target on SOPHiA GENETICS from $7.00 to $8.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th.

SOPHiA GENETICS Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.